HAYWARD, Calif. (May 13, 2009) – Alpha Orthopaedics, Inc., the manufacturer of noninvasive technologies for the treatment of musculoskeletal conditions, is pleased to announce that it has entered into a distribution agreement with Simge Pazarlama ve Mumessillik Ltd. Sti to distribute and market the AT2™ System in Turkey and Azerbaijan.

The AT2 System is the first and only medical device that equips the physicians with a truly effective tool to perform otherwise invasive procedures in a non-invasive manner.  The AT2 System is revolutionizing the way musculoskeletal conditions are treated. 

Simge, based in Ankara, has represented the world’s leading manufacturers since 1976 in the field of radiofrequency, ultrasound, and lasers. Simge has received from the Ministry of Industry and Commerce in Turkey the “After Sales Services Qualification Certificate" and is certified by TSE for their strong service network, customer support, and equipment training. Simge focuses on improving the patients' quality of life by bringing to their customers the latest innovative safe and effective solutions. The AT2 System will be the only non-invasive product on the market in Turkey and Azerbaijan for treating musculoskeletal conditions such as tennis elbow, Achilles tendinosis, and ankle sprains.

Commenting on the news, Dr. Diana Villegas, Alpha Orthopaedics’ Chief Executive Officer, said: "I am extremely delighted with this agreement. The AT2 System is a major growth opportunity for Alpha Orthopaedics, and this agreement with Simge increases our international reach into a well developed orthopaedics and sports medicine market that represents a significant commercial opportunity. We are honored to work with Simge to bring the AT2 System to physicians who treat pathologies of the ligaments and tendons, so that patients can have access to a truly effective non-invasive alternative when seeking relief from these painful and disruptive orthopaedic conditions.”